文献速递腹部泌尿生殖CT

肾实质信息对常染色体显性多囊肾病患者肾功能损害的预测价值:一项多中心前瞻性研究

The predictive value of renal parenchymal information for renal function impairment in patients with ADPKD: a multicenter prospective study.
PubMed 文献 · Abdom Radiol (NY) · 2022-05-28

该多中心前瞻性研究纳入340例肾功能正常的常染色体显性多囊肾病患者,每6个月行肾功能检查及平扫CT并随访5年,探讨肾实质体积与影像组学特征对肾功能损害的预测价值。结果显示肾实质体积较总肾体积与肾功能损害关系更密切,肾实质体积联合影像组学特征的模型预测效能进一步提高(AUC=0.902)。

要点

  • 肾实质体积下降与肾功能损害的关系较总肾体积更密切,预测AUC为0.752。
  • 基于肾实质的影像组学特征预测肾功能损害AUC达0.849。
  • 肾实质体积联合影像组学特征模型预测效能进一步提高,AUC为0.902。

核心结论

  • 肾实质信息可能是常染色体显性多囊肾病患者肾功能损害的敏感生物标志物,可为临床监测肾功能提供新途径,并可能大幅提高院前防治效果。

研究设计与样本

  • 多中心前瞻性研究,纳入340例肾功能正常的常染色体显性多囊肾病患者,每6个月行肾功能检查及平扫CT,随访5年,采用多元线性回归和多元逻辑回归分析,构建肾实质体积联合影像组学特征的组合模型。

关键影像表现/征象

  • 肾实质体积下降与肾功能损害的关系较总肾体积更密切,损害率肾实质体积为82.3%,总肾体积为67.1%。
  • 肾实质体积与eGFR的相关系数r=0.614(p<0.001),总肾体积与eGFR的相关系数r=-0.452(p<0.001)。
  • 基于肾实质提取的影像组学特征预测肾功能损害AUC=0.849(95%CI 0.797-0.892),p<0.001。

诊断标准与关键数值

  • 肾实质体积预测肾功能损害AUC=0.752(95%CI 0.692-0.805),p<0.001。
  • 总肾体积预测肾功能损害AUC=0.711(95%CI 0.649-0.768),p<0.001。
  • 肾实质体积联合影像组学特征模型预测肾功能损害AUC=0.902(95%CI 0.857-0.937),p<0.001。

临床应用与阅片要点

  • 在常染色体显性多囊肾病患者的平扫CT评估中,除总肾体积外,可关注肾实质体积及肾实质影像组学特征对肾功能损害的预测价值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Although the guideline indicates that total kidney volume (TKV) is an important detection indicator in patients with autosomal dominant polycystic kidney disease (ADPKD), this study attempted to demonstrate that renal parenchymal information, combined with parenchymal volume and radiomics features, may have more valuable clinical guiding significance.

METHODS: A totals of 340 ADPKD patients with normal renal function were prospectively collected and followed-up for five years, with renal function tests and non-contrast computed tomography (CT) performed every six months. The relationship between renal function impairment and renal parenchymal volume (RPV) as along with radiomics features was explored using a multiple linear regression model and multiple logistic regression. Then, a combined model of RPV with radiomics features was constructed to comprehensively evaluate its predictive value.

RESULTS: Compared with TKV, decreased RPV presented a closer relationship with renal function impairment, namely, with the impairment rate (RPV: 82.3% vs. TVK: 67.1%) and eGFR (RPV: r = 0.614, p < 0.001 vs. TKV: r = -0.452, p < 0.001), and showed higher predictive power (RPV: AUC = 0.752 [95%CI 0.692-0.805], p < 0.001 vs. TKV: AUC = 0.711 [95%CI 0.649-0.768], p < 0.001). Correspondingly, the radiomics analysis that was derived from the renal parenchyma also showed a satisfactory result (AUC = 0.849 [95%Cl 0.797-0.892], p < 0.001). Importantly, the predictive power for renal function impairment was further improved in the combined model of RPV and radiomics features (AUC = 0.902 [95%Cl 0.857-0.937], p < 0.001).

CONCLUSION: Renal parenchyma information may be a sensitive biomarker of renal function impairment in ADPKD, which can provide a new approach for clinically monitoring renal function, and may greatly improve the pre-hospital prevention and treatment effects.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Xie, Xu, Chen, et al. The predictive value of renal parenchymal information for renal function impairment in patients with ADPKD: a multicenter prospective study. Abdom Radiol (NY). 2022. PMID: 35633387. doi:10.1007/s00261-022-03554-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。